Assistant Professor (Former), Environmental Sciences, SIET, Shiva Group of
Institutions, Bilaspur, H.P., India
*Corresponding Author:Anju Kaushal, Assistant Professor (Former), Environmental Sciences, SIET, Shiva Group of Institutions, Bilaspur, HP, India.
Received: January 20, 2020; Published: January 31, 2020
Molecular diagnostics are the novel technologies used to commission the faster results and provide more personalized diagnosis on the basis of DNA and RNA. Genetic testing can detect the mutated genes even before the development of specific disorder and disease. Molecular diagnostics are the types of genetic tests used to diagnose, monitor and detect risks. Also help in decision making to take further steps in the prevention of disease. There are many opportunities in the growth of molecular diagnostics to watch the infectious diseases especially STIs around the globe. Market segmentation will be based on techniques, applications, end users and regions. Market definitions of analysis is evidently based on the current infectious diseases like HIV, HBV, HCV, HPV, Influenza, Tuberculosis, MRSA Staphylococcus aureus, vancomycin-resistant Enterococcus etc. Clinical laboratories, traditional market, industry structure, hospital testing share, economies of scale and POCT defined the market segmentation based on end users.
America holds the largest regional market of POC because of the prevalence of cardio vascular disease and diabetes along with rising geriatric population. By end user, hospital and clinics are accounted for 85% of share. PCR, real-time PCR, fluorescent in-situ hybridization, microarray, and NGS are expected to grow at a CAGR of 9.6% by 2023. Market is established in the region wise in America, Europe, Asia Pacific region, Pacific/Middle Eastern region and India, Australia, and Japan will hold country specific market.
Keywords: Molecular Diagnostics; Genetic Testing; Infectious Diseases; Gene; Market Segment
Citation: Anju Kaushal. “Global Molecular Diagnostics Market Expands Rapidly with Enormous Potentials in Infectious Diseases and Cancer". Acta Scientific Microbiology 3.2 (2020): 129-132.
Copyright: © 2020 Anju Kaushal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.